Biodexa Pharmaceuticals (BDRX) Short Interest Ratio & Short Volume $1.39 +0.09 (+6.92%) Closing price 04:00 PM EasternExtended Trading$1.22 -0.17 (-12.30%) As of 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock Biodexa Pharmaceuticals Short Interest DataBiodexa Pharmaceuticals (BDRX) has a short interest of 228,000 shares. This marks a -21.43% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 825,372 shares to cover all short positions.Current Short Interest228,000 sharesPrevious Short Interest290,200 sharesChange Vs. Previous Month-21.43%Dollar Volume Sold Short$332,880.00Short Interest Ratio0.1 Days to CoverLast Record DateApril 30, 2025Outstanding Shares36,544,000 sharesPercentage of Shares Shorted0.62%Today's Trading Volume62,690,079 sharesAverage Trading Volume825,372 sharesToday's Volume Vs. Average7,595% Short Selling Biodexa Pharmaceuticals? Sign up to receive the latest short interest report for Biodexa Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartBDRX Short Interest Over TimeBDRX Days to Cover Over TimeBDRX Percentage of Float Shorted Over Time Biodexa Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2025228,000 shares $332,880.00 -21.4%N/A0.1 $1.46 4/15/2025290,200 shares $423,692.00 +323.7%0.8%0.2 $1.46 3/31/202568,500 shares $90,420.00 +10.3%0.2%0 $1.32 3/15/202562,100 shares $117,990.00 +72.0%0.2%0 $1.90 2/28/202536,100 shares $120,213.00 -23.2%0.1%0 $3.33 2/15/202547,000 shares $200,690.00 +1,368.8%0.1%0.1 $4.27 1/31/20253,200 shares $14,112.00 -50.8%N/A0 $4.41 1/15/20256,500 shares $27,787.50 -37.5%N/A0 $4.28 12/31/202410,400 shares $42,120.00 -62.6%N/A0 $4.05 12/15/202427,800 shares $116,760.00 -46.5%N/A0.1 $4.20 Get the Latest News and Ratings for BDRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Biodexa Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 11/30/202452,000 shares $292,240.00 +225.0%N/A0.2 $5.62 11/15/202416,000 shares $57,920.00 +15.9%N/A0.1 $3.62 10/31/202413,800 shares $84,870.00 -50.2%N/A0.1 $6.15 10/15/202427,700 shares $138,777.00 +108.3%N/A0.2 $5.01 9/30/202413,300 shares $3,753.26 -83.7%N/A0.2 $0.28 9/15/202481,400 shares $33,536.80 -5.2%N/A0.1 $0.41 8/31/202485,900 shares $47,245.00 -17.7%N/A0.1 $0.55 8/15/2024104,400 shares $63,130.68 +63.4%N/A0.1 $0.60 7/31/202463,900 shares $44,091.00 -89.2%N/A0 $0.69 7/15/2024589,700 shares $572,009.00 +318.5%N/A0.1 $0.97 6/30/2024140,900 shares $126,232.31 -35.6%N/A0 $0.90 6/15/2024218,800 shares $214,642.80 -34.6%N/A0 $0.98 5/31/2024334,700 shares $322,784.68 +3.9%N/A0.1 $0.96 5/15/2024322,000 shares $363,860.00 -84.4%N/A0.1 $1.13 4/30/20242,060,000 shares $3.11 million +986.5%N/A0.6 $1.51 4/15/2024189,600 shares $157,974.72 +183.8%N/A0.1 $0.83 3/31/202466,800 shares $108,216.00 -34.9%N/A0 $1.62 3/15/2024102,600 shares $120,042.00 -32.3%N/A0.2 $1.17 2/29/2024151,600 shares $192,532.00 -37.1%N/A0.3 $1.27 2/15/2024241,100 shares $383,349.00 +414.1%N/A0.2 $1.59 1/31/202446,900 shares $75,509.00 +3.3%N/A0.1 $1.61 1/15/202445,400 shares $91,254.00 -46.7%N/A0.1 $2.01 12/31/202385,100 shares $228,068.00 -51.8%N/A0.1 $2.68 12/15/2023176,500 shares $524,205.00 -43.3%N/A0.3 $2.97 11/30/2023311,300 shares $1.13 million +3,044.4%N/A0.5 $3.62 11/15/20239,900 shares $25,344.00 -5.7%N/A0 $2.56 10/31/202310,500 shares $39,690.00 -61.5%N/A0 $3.78 10/15/202327,300 shares $132,132.00 +875.0%N/A0.1 $4.84 9/30/20232,800 shares $13,972.00 -63.6%N/A0 $4.99 9/15/20237,700 shares $47,586.00 -64.2%N/A0 $6.18AI Meltdown Imminent: Dump These Stocks Now! (Ad)If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new invention… This could send many popular AI stocks crashing, including Nvidia. And it could happen starting as soon as June 1st.Click here to see the details and learn how to prepare for the next AI revolution 8/31/202321,500 shares $171,785.00 -28.3%N/A0 $7.99 8/15/202330,000 shares $148,800.00 -50.3%N/A0.1 $4.96 7/31/202360,300 shares $328,635.00 -27.1%N/A0.1 $5.45 7/15/202382,700 shares $445,753.00 +100.2%N/A0.3 $5.39 6/30/202341,300 shares $226,654.40 -85.5%N/A0.3 $5.49 6/15/2023284,600 shares $22,141.88 +156.2%N/A0.1 $0.08 5/31/2023111,100 shares $9,332.40 -37.8%N/A0 $0.08 5/15/2023178,700 shares $40,475.55 No ChangeN/A0.1 $0.23 3/15/202384,900 shares $118,860.00 +41.7%N/A1.6 $1.40 2/28/202359,900 shares $31,148.00 +0.5%N/A1.2 $0.52 2/15/202359,600 shares $37,548.00 +111.4%N/A1.3 $0.63 1/31/202328,200 shares $19,742.82 +18.0%N/A0.7 $0.70 1/15/202323,900 shares $15,535.00 -38.2%N/A0.8 $0.65 12/30/202238,700 shares $38,119.50 +26.9%N/A2 $0.99 12/15/202230,500 shares $24,403.05 +254.7%N/A1.7 $0.80 11/30/20228,600 shares $13,674.00 -1.2%N/A0.4 $1.59 11/15/20228,700 shares $13,892.16 +6.1%N/A0.4 $1.60 10/31/20228,200 shares $15,908.00 +310.0%N/A0.3 $1.94 10/15/20222,000 shares $3,848.60 -39.4%N/A0.1 $1.92 9/30/20223,300 shares $6,138.00 -61.6%N/A0.1 $1.86 9/15/20228,600 shares $28,638.00 -74.2%N/A0.4 $3.33 8/31/202233,300 shares $24,642.00 +69.0%N/A0.7 $0.74 8/15/202219,700 shares $14,676.50 -63.3%N/A0.1 $0.75 7/31/202253,700 shares $35,168.13 +47.9%N/A0.3 $0.65 7/15/202236,300 shares $26,136.00 -44.8%N/A0.2 $0.72 6/30/202265,800 shares $35,532.00 -24.2%N/A0.3 $0.54 6/15/202286,800 shares $44,935.49 +617.4%N/A0.4 $0.52 5/31/202212,100 shares $7,578.46 -28.8%N/A0.1 $0.63 5/15/202217,000 shares $8,924.98 +794.7%N/A0.3 $0.52 4/30/20221,900 shares $1,235.00 -93.7%N/A0 $0.65 4/15/202230,100 shares $25,886.00 -28.8%N/A0.5 $0.86 3/31/202242,300 shares $37,224.00 +6.0%N/A0.7 $0.88 3/15/202239,900 shares $32,953.37 +17.0%N/A0.5 $0.83 2/28/202234,100 shares $33,452.10 -55.3%N/A0.3 $0.98 2/15/202276,300 shares $76,071.10 +149.4%N/A0.6 $1.00 1/31/202230,600 shares $30,906.00 -42.8%N/A0.2 $1.01 1/15/202253,500 shares $60,455.00 +59.7%N/A0.4 $1.13 12/31/202133,500 shares $35,175.00 -83.7%N/A0.2 $1.05 12/15/2021205,800 shares $234,612.00 +53.5%N/A1.6 $1.14 11/30/2021134,100 shares $195,786.00 +9.2%N/A1.4 $1.46 11/15/2021122,800 shares $200,164.00 -31.3%N/A1.2 $1.63 10/29/2021178,700 shares $303,790.00 +19.1%N/A1.8 $1.70 10/15/2021150,000 shares $255,750.00 +1.6%N/A1.4 $1.71 9/30/2021147,600 shares $256,824.00 -12.4%N/A1.2 $1.74 9/15/2021168,500 shares $291,505.00 +1.9%N/A1.1 $1.73 8/31/2021165,400 shares $302,682.00 -34.0%N/A0.1 $1.83 8/13/2021250,600 shares $455,315.14 -9.4%N/A0.1 $1.82 7/30/2021276,700 shares $514,662.00 +0.8%N/A0.1 $1.86 7/15/2021274,600 shares $503,891.00 -18.0%N/A0.1 $1.84 6/30/2021334,700 shares $696,176.00 +102.2%N/A0.2 $2.08AI Meltdown Imminent: Dump These Stocks Now! (Ad)If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new invention… This could send many popular AI stocks crashing, including Nvidia. And it could happen starting as soon as June 1st.Click here to see the details and learn how to prepare for the next AI revolution 6/15/2021165,500 shares $331,000.00 No ChangeN/A0.1 $2.00 5/28/2021165,500 shares $316,105.00 -7.9%N/A0.7 $1.91 5/14/2021179,700 shares $359,400.00 +10.5%N/A0.6 $2.00 4/30/2021162,600 shares $320,322.00 +7.4%N/A0.4 $1.97 4/15/2021151,400 shares $307,342.00 -15.7%N/A0.2 $2.03 3/31/2021179,500 shares $384,130.00 +7.1%N/A0.2 $2.14 3/15/2021167,600 shares $398,888.00 -13.8%N/A0.2 $2.38 2/26/2021194,400 shares $480,168.00 -5.6%N/A0.2 $2.47 2/12/2021206,000 shares $585,040.00 +89.3%N/A0.2 $2.84 1/29/2021108,800 shares $233,920.00 +1.2%N/A0.1 $2.15 1/15/2021107,500 shares $245,100.00 -36.1%N/A0.3 $2.28 12/31/2020168,200 shares $319,580.00 +43.5%N/A0.4 $1.90 12/15/2020117,200 shares $227,496.92 +2.5%N/A0.3 $1.94 11/30/2020114,400 shares $208,208.00 -16.3%N/A0.3 $1.82 11/15/2020136,600 shares $260,906.00 -12.1%N/A0.4 $1.91 10/30/2020155,400 shares $289,044.00 +50.0%N/A0 $1.86 10/15/2020103,600 shares $198,912.00 -3.6%N/A0 $1.92 9/30/2020107,500 shares $194,575.00 -7.7%N/A0 $1.81 9/15/2020116,500 shares $228,340.00 -48.7%N/A0 $1.96 8/31/2020227,100 shares $526,872.00 +4,731.9%N/A0 $2.32 8/14/20204,700 shares $12,784.00 -99.6%N/A0 $2.72 7/31/20201,120,000 shares $2.28 million +5,585.3%N/A0.3 $2.04 7/15/202019,700 shares $25,413.00 +146.3%N/A0 $1.29 6/30/20208,000 shares $11,120.00 -73.6%N/A0 $1.39 6/15/202030,300 shares $42,117.00 +83.6%N/A0.1 $1.39 5/29/202016,500 shares $22,935.00 +96.4%N/A0.1 $1.39 BDRX Short Interest - Frequently Asked Questions What is Biodexa Pharmaceuticals' current short interest? Short interest is the volume of Biodexa Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 228,000 shares of BDRX short. Learn More on Biodexa Pharmaceuticals' current short interest. Is Biodexa Pharmaceuticals' short interest increasing or decreasing? Biodexa Pharmaceuticals saw a decrease in short interest in April. As of April 30th, there was short interest totaling 228,000 shares, a decrease of 21.4% from the previous total of 290,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Biodexa Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Biodexa Pharmaceuticals: ADC Therapeutics SA (4.51%), scPharmaceuticals Inc. (4.32%), Nanobiotix S.A. (0.01%), DiaMedica Therapeutics Inc. (1.45%), Inhibrx, Inc. (7.27%), ProQR Therapeutics (0.36%), INmune Bio, Inc. (25.37%), Puma Biotechnology, Inc. (7.53%), Organigram Holdings Inc. (8.03%), AC Immune SA (2.25%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology S.A. ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit, Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks. What does it mean to sell short Biodexa Pharmaceuticals stock? Short selling BDRX is an investing strategy that aims to generate trading profit from Biodexa Pharmaceuticals as its price is falling. BDRX shares are trading up $0.09 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Biodexa Pharmaceuticals? A short squeeze for Biodexa Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BDRX, which in turn drives the price of the stock up even further. How often is Biodexa Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BDRX, twice per month. The most recent reporting period available is April, 30 2025. More Short Interest Resources from MarketBeat Related Companies ADC Therapeutics Short Interest Data scPharmaceuticals Short Interest Data Nanobiotix Short Interest Data DiaMedica Therapeutics Short Interest Data Inhibrx Short Interest Data ProQR Therapeutics Short Interest Data INmune Bio Short Interest Data Puma Biotechnology Short Interest Data Organigram Short Interest Data AC Immune Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BDRX) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredElon’s backup plan for AIElon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biodexa Pharmaceuticals Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Biodexa Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BDRX Stock Free BDRX Stock Alerts